Viewing StudyNCT00272740



Ignite Creation Date: 2024-05-05 @ 4:35 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00272740
Status: COMPLETED
Last Update Posted: 2007-02-09
First Post: 2006-01-04

Brief Title: SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex After Aromatase Inhibitor Failure in Advanced Breast Cancer
Sponsor: AstraZeneca
Organization: AstraZeneca

Organization Data

Organization: AstraZeneca
Class: INDUSTRY
Study ID: 9238SZ0001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: AstraZeneca
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators